Multidisciplinary Approach to Reduce Cardiovascular Health Disparities in the Baltimore RAcial Minority CommunitiEs (M-BRACE Trial)
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY
The goal of this observational study is to investigate the potential differences in thrombogenicity between black and white patients admitted with atherothrombotic events including acute coronary syndrome, multi-vessel coronary disease, and ischemic stroke. Participants will engage in laboratory testing and health outcome assessments.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients ≥18 years of age admitted with ACS, AIS, or multi-vessel CAD
• Competent mental condition to provide informed consent and able to participate in follow-ups
Locations
United States
Maryland
Sinai Hospital of Baltimore
RECRUITING
Baltimore
Contact Information
Primary
Kevin Bliden, BS, MBA
kbliden@lifebridgehealth.org
4432441497
Time Frame
Start Date: 2023-02-06
Estimated Completion Date: 2025-12
Participants
Target number of participants: 400
Treatments
Patient
(Secondary Prevention) Includes black (n=150) and white (n=150) patients greater than or equal to 18 years of age hospitalized for acute coronary syndrome (ACS), multi-vessel disease, or ischemic stroke undergoing intervention
Family Member
(Primary Prevention) Includes black subjects (n=75) who are first or second-degree relatives of patients in Cohort 1 and have no history of prior hospitalization for cardiovascular or cerebrovascular disease
Related Therapeutic Areas
Sponsors
Leads: LifeBridge Health
Collaborators: University of Maryland